Related Experiment Video
Updated: Feb 27, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Hemodialysis treatment of cardiorenal syndrome
Insights
Hemodialysis significantly reduced heart failure hospital readmissions and duration of stay in cardiorenal syndrome patients. This renal replacement therapy improved survival rates compared to the general NYHA IV population.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Cardiorenal syndrome (CRS) involves complex interactions between heart and kidney dysfunction.
- Patients with advanced CRS (NYHA IV) often face high mortality and frequent hospitalizations.
- Management of fluid overload and kidney function is critical in CRS patients.
Purpose of the Study:
- To evaluate the impact of hemodialysis on mortality and hospital readmission in patients with cardiorenal syndrome.
- To assess the effectiveness of hemodialysis as a renal replacement therapy in advanced heart failure patients.
Main Methods:
- A cohort of 67 NYHA IV patients with cardiorenal syndrome underwent hemodialysis.
- Indications for hemodialysis included progressive kidney decline, heart failure medication intolerance, or refractory hypervolemia.
- Patients received low-efficacy bicarbonate hemodialysis with central venous catheter access.
Main Results:
- Hemodialysis led to a significant decrease in heart failure hospital readmissions (0.79 to 0.22 per year).
- Annual hospital stay duration was reduced (11.4 to 3.7 days).
- 1-, 2-, 3-, 4-, and 5-year survival rates were 81%, 61%, 52%, 47%, and 39%, respectively.
Conclusions:
- Chronic hemodialysis with strict control of uremia, electrolytes, and volume may benefit advanced heart failure patients.
- Hemodialysis demonstrated improved survival and reduced hospital readmissions compared to ultrafiltration alone in terminal CRS.
- This approach offers a better prognosis for cardiorenal syndrome patients than previously observed in the general NYHA IV population.
Aims:
We evaluated the impact of hemodialysis on mortality and hospital readmission in patients with cardiorenal syndrome.
Methods:
All patients were NYHA IV functional class and underwent laboratory testing, echocardiography, and cardiac functional testing. Hemodialysis was indicated in patients with progressive decline of kidney function and consequent failure to titrate heart failure medication as well as in patients with hypervolemia that was resistant to conservative treatment with more than 4 annual hospitalizations due to heart failure and/or concomitant chronic kidney disease stage III - IV. Patients were treated with low-efficacy bicarbonate hemodialysis with permanent central venous catheter used as vascular access.
Results:
Since 2004, 67 patients were started on hemodialysis because of cardiorenal syndrome. Hospital readmission rate due to heart failure decreased (1 year before dialysis vs. 1 year after dialysis: 0.79 ± 1.32 vs. 0.22 ± 0.65 hospitalizations per year, p = 0.001) together with the duration of annual hospital stay (11.4 ± 21.4 vs. 3.7 ± 10.4 days, p = 0.011). 1-, 2-, 3-, 4- and 5-year survival for our patients was 81%, 61%, 52%, 47%, and 39%, respectively.
Conclusions:
Chronic renal replacement therapy with hemodialysis and strict uremic, electrolyte, and volume control may be more beneficial for patients with advanced heart failure with preserved or reduced LVEF than ultrafiltration alone. We have observed better survival of terminal cardiorenal patients treated with hemodialysis than in the general NYHA IV population, with lower hospital readmission rate and less hospitalized days for heart failure. .
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

